Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Comfort-Focused education program improve life with epilepsy?

NCT ID NCT07827248

Symptom relief Sponsor: Ataturk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

Researchers are testing whether a structured educational program based on Kolcaba's Comfort Theory can improve quality of life for adults with epilepsy. The program addresses physical, emotional, social, and environmental comfort needs through planned sessions delivered alongside routine care. About 80 participants will be assigned to either the education program plus routine care or routine care alone. Quality of life is measured before and after the intervention using a validated epilepsy-specific scale.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a structured educational program based on Kolcaba's Comfort Theory
What this could lead to
If it works, this could give epilepsy care teams a low-cost, non-drug way to help patients feel more comfortable and improve daily quality of life.
What could go wrong
This is a small, single-center study of an educational program, so results may not apply broadly. Education alone may not change quality of life for everyone, and any benefits could fade without ongoing support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being 18 years of age or older * Having a diagnosis of epilepsy for at least 6 months * Being able to read and write in Turkish * Having access to a reachable telephone for communication * Clinical diagnosis and hospital records will be used to confirm eligibility criteria, along with participant self-report Exclusion Criteria: * Presence of psychiatric disorders affecting cognitive processes (e.g., dementia, schizophrenia) * Having chronic diseases other than epilepsy * Being pregnant * Willingness to withdraw from the study at any stage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epilepsy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epilepsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ağrı Eğitim ve Araştırma Hastanesi

    Ağrı, Ağrı, 04100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.